Anticancer effects of PEP06 (TB01) in combination with Trifluridine/Tipiracil (TAS-102) in a xenograft model of human colorectal cancer
The synergistic effect observed from the combined use of TAS-102 and TB01 suggests a promising new treatment avenue for refractory CRC patients, meriting further investigation and potential clinical application.
Authors
- Jiaxing Cheng (ORCID: https://orcid.org/0000-0001-8354-6452)
- Liang Zhou (ORCID: https://orcid.org/0000-0003-0188-2044)
- Xinchun Yang (ORCID: https://orcid.org/0000-0001-9813-8347)
- Ruohong Lin
- Jian Li (ORCID: https://orcid.org/0000-0002-8555-1420)
- Jinlong Zhao (ORCID: https://orcid.org/0000-0003-4594-0461)
Institutions
- Shenyang Pharmaceutical University (CN)
- East China University of Science and Technology (CN)
- Gree (China) (CN)
Publication Details
- Journal
- Journal of Cancer Research and Clinical Oncology
- Published
- 2024-12-26
- DOI
- https://doi.org/10.1007/s00432-024-05984-z
- Citations
- 1
- Primary Topic
- Colorectal Cancer Treatments and Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.28